HCPCS code J9025: Azacitidine injection, per 1 mg2026 Medicare rate & RVUs in Massachusetts
Reports injectable azacitidine given in cancer treatment, with each HCPCS unit representing 1 mg of the drug administered.
CMS doesn’t publish an office rate for J9025 in Massachusetts.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J9025 covers
Azacitidine is an antineoplastic drug used in treatment of myelodysplastic syndromes and certain cases of acute myeloid leukemia. Oncology practices and hospital-based cancer services report this drug code for azacitidine administered by subcutaneous injection or intravenous infusion. The code identifies the drug, not the route or the administration service.
Medicare assigns this code physician fee schedule status E, meaning it is excluded from the physician fee schedule. When Medicare covers the drug, it is treated as a Part B drug and generally priced using CMS quarterly Average Sales Price drug files; coverage is left to the Medicare contractor. Report the amount administered in 1 mg units: for example, 100 mg corresponds to 100 units. Report the applicable drug-administration service separately when appropriate.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J9025 pays more and less in Massachusetts
| Payment locality | Office | Facility |
|---|---|---|
| Metropolitan Boston, MA | Unavailable | Unavailable |
| Rest of Massachusetts | Unavailable | Unavailable |
How the J9025 rate is calculated
Each of J9025’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J9025
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J9025
J9025 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J9025
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J9025 isn’t priced in this setting.
J9025 compared with similar codes
Compare codes · National
J9025 vs J0894 vs J9026: Medicare rates
How to choose
- J0894Decitabine injectionPer 1 mg
- J0894 identifies decitabine, not azacitidine. Use J9025 for azacitidine actually administered and J0894 for decitabine.
- J9026Tarlatamab injectionPer 1 mg
- J9026 identifies tarlatamab-dlle, a different antineoplastic drug. The neighboring code number does not indicate an azacitidine formulation or dose.
J9025 billing questions
How many units should be reported?
Each unit represents 1 mg of azacitidine. Calculate units from the amount administered in milligrams.
Does this code include drug administration?
No. J9025 identifies the azacitidine drug; report an applicable administration service separately when appropriate.
How is J9025 different from decitabine code J0894?
J9025 is azacitidine, while J0894 is decitabine. Select the code for the drug actually administered; they are distinct agents, not interchangeable drug codes.
Does Medicare pay J9025 under the physician fee schedule?
No. CMS assigns status E, excluding it from the physician fee schedule. When covered, Medicare generally pays it as a Part B drug using the applicable CMS quarterly ASP pricing file.
Who determines whether Medicare covers azacitidine?
Coverage is left to the Medicare contractor's judgment.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J9025 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist